Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Low Grade Serous Ovarian Carcinoma · Adult Type Granulosa Cell Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • CHU de Liège, Liège, Liège, Belgium

    Contact: Study coordinator (Frédéric Kridelka, MD) · Frederic.Kridelka@chuliege.be · +3243237169
    Contact: Principal Investigator (Frédéric Kridelka, MD)
  • UZ Gent, Ghent, Oost-Vlaanderen, Belgium

    Contact: Study coordinator (Hannelore Denys, MD PhD) · hannelore.denys@uzgent.be · +3293322692
    Contact: Principal Investigator (Hannelore Denys, MD PhD)
  • UZ Leuven, Leuven, Vlaams-Brabant, Belgium

    Contact: Study coordinator (Els Van Nieuwenhuysen, MD PhD) · els.vannieuwenhuysen@uzleuven.be · +3216342531
    Contact: Study coordinator (Tine Ottenbourgs) · tine.ottenbourgs@uzleuven.be · +3216348131
    Contact: Principal Investigator (Els Van Nieuwenhuysen, MD PhD)
  • Institut De Cancerologie Strasbourg Europe, Strasbourg, Bas-Rhin, France

    Contact: Study coordinator (Lauriane Eberst, MD) · l.eberst@icans.eu
    Contact: Principal Investigator (Lauriane Eberst, MD)
  • Institut Bergonie, Bordeaux, Gironde, France

    Contact: Study coordinator (Coriolan Lebreton, MD) · c.lebreton@bordeaux.unicancer.fr
    Contact: Principal Investigator (Coriolon Lebreton, MD)
  • Institut Universitaire Du Cancer Toulouse-Oncopole, Toulouse, Haute-Garonne, France

    Contact: Study coordinator (Laurence Gladieff, MD) · gladieff.laurence@iuct-oncopole.fr
    Contact: Principal Investigator (Laurence Gladieff, MD)
  • Institut De Cancerologie De L'Ouest, Saint-Herblain, Loire-Atlantique, France

    Contact: Study coordinator (Dominique Berton, MD) · Dominique.berton@ico.unicancer.fr
    Contact: Principal Investigator (Dominique Berton, MD)
  • Centre Leon Berard, Lyon, Métropole de Lyon, France

    Contact: Study coordinator (Isabelle Ray-Coquard, MD PhD) · isabelle.ray-coquard@lyon.unicancer.fr
    Contact: Principal Investigator (Isabelle Ray-Coquard, MD PhD)
  • Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, Île-de-France Region, France

    Contact: Study coordinator (Frédéric Selle, MD) · fselle@hopital-dcss.org
    Contact: Principal Investigator (Frédéric Selle, MD)
  • University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands

    Contact: Study coordinator (Hilde Jalving, MD) · m.jalving@umcg.nl
    Contact: Principal Investigator (Hilde Jalving, MD)
  • Erasmus Medical Center Rotterdam, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Ingrid Boere, MD) · i.boere@erasmusmc.nl
    Contact: Principal Investigator (Ingrid Boere, MD)
  • University Medical Center Utrecht, Utrecht, Utrecht, Netherlands

    Contact: Study coordinator (Inge Baas, MD) · I.O.Baas-3@umcutrecht.nl
    Contact: Principal Investigator (Inge Baas, MD)
Study leads
  • Els Van Nieuwenhuysen, MD PhD

    Principal Investigator

    UZ Leuven